The new version of medical insurance catalog is officially implemented! Good news for chronic patients

[industry trends of pharmaceutical network] from January 1, 2020, the new version of medical insurance catalog will be officially implemented 70 new drugs were added in the medical insurance negotiation, including national essential drugs, drugs for treatment of major diseases such as cancer and rare diseases, drugs for chronic diseases, drugs for children, and drugs newly listed in recent years with high clinical value, with an average decrease of 60.7% in the price of new drugs; 27 drugs continued, with an average decrease of 26.4% The industry expects that the burden of patients will be reduced by more than 80% and that of individual drugs by more than 95% Among them, the average decrease rate of three kinds of hepatitis C treatment drugs is more than 85%, and the average decrease rate of cancer, diabetes and other treatment drugs is about 65% The implementation of the new health insurance catalog is a great blessing for patients with chronic diseases For example, the original purchase price of irbesartan hydrochlorothiazide tablets for the treatment of essential hypertension was 4.18 yuan / tablet, and the selected price was 1.09 yuan / tablet Based on taking one tablet every day, the treatment cost decreased by 74.2%; the original purchase price of gefitinib tablets for the treatment of non-small cell lung cancer was 158.4 yuan / tablet, and the selected price was 25.7 yuan / tablet, with a decrease of 83.8% The treatment cost for one month decreased from 4800 yuan to 770 yuan The average reimbursement rate is 70%, and the individual only needs to pay 230 yuan According to the notice on the implementation of national medical insurance negotiation drugs in 2019, each provincial medical insurance department shall, within the specified time limit, directly "hang up" 97 medical insurance negotiation drugs on the provincial drug centralized purchase platform to ensure the timely implementation of the new medical insurance catalog At present, Jiangxi, Hubei, Tianjin, Henan and other places have released the news of officially implementing the new version of the medical insurance catalog Since January 1, Jiangxi Province has fully implemented the new version of the medical insurance catalog, and has made it clear that in the future, each overall planning area of Jiangxi Province shall not adjust the limited payment scope of the drugs in the catalog, and shall not make the catalog or add the drugs in the catalog by flexible methods The key monitoring drugs must be withdrawn from the catalogue at one time It is reported that the new version of the medical insurance catalogue will be implemented this time, and 3601 drugs will be reimbursed by medical insurance in Jiangxi Among them, there are 2595 conventional access drugs, including 1279 western drugs and 1316 Chinese patent drugs (including 93 national drugs); 892 pieces of Chinese herbal medicines included in the first access method; 114 drugs for negotiation access Since January 1, Tianjin has included all the conventional access varieties increased by the adjustment of the new version of the medical insurance catalogue into the medical insurance payment scope of the city, and all the drugs successfully negotiated by the state have been included in the class B management of the medical insurance medicine catalogue of the city This time, a total of 347 new drugs have been adjusted and 360 drugs have been removed It is reported that after the implementation of the new version of the medical insurance drug catalog, Tianjin Medical Security Bureau will also strengthen the monitoring and analysis of the implementation of the catalog, prevent unreasonable expenditure, severely punish fraud and insurance fraud, and ensure the drug demand of insured patients Hubei Province has officially implemented the new version of the medical insurance drug catalog since January 1 Hubei Province requires strict implementation of the unified national payment standard for drugs negotiated by the state In addition, according to the national unified deployment, Hubei Province plans to use three years to digest, adjust and delete the original provincial supplementary drugs year by year It is reported that Hubei Province will give priority to the country, the province and other provinces as the key monitoring range of drugs (mainly supplementary drugs for nutrients, immune enhancers, blood circulation and stasis removing and other auxiliary drugs, which are heavily burdened with costs and have uncertain curative effects), as the key adjustment objects, and resolutely delete them After deleting the adjustment, the above drugs will no longer be included in the payment of medical insurance fund, and the saving fund will be used to improve the protection of people's serious and serious diseases.